The International Prognostic Score and HIV status predict red cell concentrate transfusion needs in Hodgkin lymphoma

References

• Meyer RM, Gospodarowicz MK, Connors JM, et al. ABVD alone versus radiation-based therapy in limited-stage Hodgkin’s lymphoma. N Engl J Med. 2012;366(5):399–408.
   PubMed Web of Science ®Google Scholar
• Canellos GP, Anderson JR, Propert KJ, et al. Chemotherapy of advanced Hodgkin’s disease with MOPP, ABVD, or MOPP alternating with ABVD. N Engl J Med. 1992;327(21):1478–1484.
   PubMed Web of Science ®Google Scholar
• Silverberg MJ, Lau B, Achenbach CJ, et al. Cumulative incidence of cancer among persons with HIV in North America: a cohort study. Ann Intern Med. 2015;163(7):507–518.
   PubMed Web of Science ®Google Scholar
• James SL, Abate D, Abate KH, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392(10159):1789–1858.
   PubMed Web of Science ®Google Scholar
• Eichenauer DA, Bredenfeld H, Haverkamp H, et al. Hodgkin’s lymphoma in adolescents treated with adult protocols : a report from the German Hodgkin Study Group. J Clin Oncol. 2009;27(36):6079–6085.
   PubMed Web of Science ®Google Scholar
• Boo YL, Siew H, Ting Y, et al. Clinical features and treatment outcomes of Hodgkin lymphoma: a retrospective review in a Malaysian tertiary hospital. Blood Res. 2019;54(3):210–217.
   PubMed Web of Science ®Google Scholar
• Biasoli I, Castro N, Delamain M, et al. Treatment outcomes for Hodgkin lymphoma: first report from the Brazilian Prospective Registry. Hematol Oncol. 2018;36(1):189–195.
   PubMed Web of Science ®Google Scholar
• Wen Q, Ge J, Lei Y, et al. Real‑world evidence of ABVD‑like regimens compared with ABVD in classical Hodgkin lymphoma: a 10‑year study from China. J Cancer Res Clin Oncol. 2022;1–15.
   Google Scholar
• Montoto S, Shaw K, Okosun J, et al. HIV status does not influence outcome in patients with classical Hodgkin lymphoma treated with chemotherapy using doxorubicin, bleomycin, vinblastine, and dacarbazine in the highly active antiretroviral therapy era. J Clin Oncol. 2012;30(33):4111–4116.
   PubMed Web of Science ®Google Scholar
• Besson C, Lancar R, Prevot S, et al. High risk features contrast with favorable outcomes in HIV-associated Hodgkin lymphoma in the modern cART Era, ANRS CO16 LYMPHOVIR cohort. Clin Infect Dis. 2015;61(9):1469–1475.
   PubMed Web of Science ®Google Scholar
• Takuva S, Maskew M, Brennan AT, et al. Anemia among HIV-Infected patients initiating antiretroviral therapy in South Africa: improvement in hemoglobin regardless of degree of immunosuppression and the initiating ART regimen. J Trop Med. 2013;2013:162950.
   PubMedGoogle Scholar
• Ntusi NBA, Sonderup MW. HIV/AIDS affects blood and blood product use at Groote Schuur Hospital, Cape Town. S Afr Med J. 2011;101(7):463–466.
   PubMed Web of Science ®Google Scholar
• Kerkhoff AD, Lawn SD, Schutz C, et al. Anemia, blood transfusion requirements and mortality risk in human immunodeficiency virus-infected adults requiring acute medical admission to hospital in South Africa. Open Forum Infect Dis. 2015;2(4):ofv173.
   PubMedGoogle Scholar
• Antel K, Levetan C, Mohamed Z, et al. The determinants and impact of diagnostic delay in lymphoma in a TB and HIV endemic setting. BMC Cancer. 2019;19(1):384.
   PubMedGoogle Scholar
• Puvaneswaran B, Shoba B. Misdiagnosis of tuberculosis in patients with lymphoma. S Afr Med J. 2012;103(1):32–33.
   PubMed Web of Science ®Google Scholar
• Antel K, Louw VJ, Maartens G, et al. Diagnosing lymphoma in the shadow of an epidemic: lessons learned from the diagnostic challenges posed by the dual tuberculosis and HIV epidemics. Leuk Lymphoma. 2020;61(14):3417–3421.
   PubMed Web of Science ®Google Scholar
• Naidoo N, Bch MB, Abayomi A, et al. Incidence of Hodgkin lymphoma in HIV-positive and HIV-negative patients at a tertiary hospital in South Africa (2005–2016) and comparison with other African countries. S Afr Med J. 2018;108(7):563–567.
   Web of Science ®Google Scholar
• HIV and AIDS in South Africa | Avert; 2021 [Internet] [cited 2021 Mar 15]. Available from: https://www.avert.org/professionals/hiv-around-world/sub-saharan-africa/south-africa
   Google Scholar
• Hasenclever D, Diehl V. A prognostic score for advanced Hodgkin’s disease. International Prognostic Factors project on advanced Hodgkin’s disease. N Engl J Med. 1998;339(21):1506–1514.
   PubMed Web of Science ®Google Scholar
• Ganesan P, Dhanushkodi M, Ganesan TS, et al. Prognostic utility of the IPS 3 Score for predicting outcomes in advanced Hodgkin lymphoma. Clin Lymphoma Myeloma Leuk. 2019;19(2):116–122.
   PubMed Web of Science ®Google Scholar
• Diefenbach CS, Li H, Hong F, et al. Evaluation of the International Prognostic Score (IPS-7) and a simpler prognostic score (IPS-3) for advanced Hodgkin lymphoma in the modern era. Br J Haematol. 2015;171(4):530–538.
   PubMed Web of Science ®Google Scholar
• Hohaus S, Vannata B, Giachelia M, et al. Anemia in Hodgkin lymphoma: the role of interleukin-6 and hepcidin. Blood. 2009;114(22):3656–3656.
   PubMed Web of Science ®Google Scholar
• Birgegård G, Gascón P, Ludwig H. Evaluation of anaemia in patients with multiple myeloma and lymphoma: findings of the European Cancer Anaemia Survey. Eur J Haematol. 2006;77(5):378–386.
   PubMed Web of Science ®Google Scholar
• Ali S, Ali M, Badar F, et al. Factors associated with increased red blood cells transfusion requirements in patients with Hodgkin and non-Hodgkin lymphoma. J Ayub Med Coll Abbottabad. 2015;27(1):70–73.
   PubMedGoogle Scholar
• Engert A, Josting A, Haverkamp H, et al. Epoetin alfa in patients with advanced-stage Hodgkin’s lymphoma: results of the randomized placebo-controlled GHSG HD15EPO trial. J Clin Oncol. 2010;28(13):2239–2245.
   PubMed Web of Science ®Google Scholar
• Buccheri G, Ferrigno D, Tamburini M. Karnofsky and ECOG performance status scoring in lung cancer: a prospective, longitudinal study of 536 patients from a single institution. Eur J Cancer. 1996;32A(7):1135–1141.
   PubMed Web of Science ®Google Scholar
• Swerdlow SH, Campo E, Harris NL, et al. WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon, France: World Health Organization Classification of Tumours of Haematopoietic and Lymphoid Tissue; 2017.
   Google Scholar
• Cheson BD, Fisher RI, Barrington SF, et al. Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification. J Clin Oncol. 2014;32(27):3059–3068.
   PubMed Web of Science ®Google Scholar
• Hoppe RT, Advani RH, Ai WZ, et al. Hodgkin lymphoma, version 2.2020. J Natl Compr Canc Netw. 2020;18(6):755–781.
   PubMed Web of Science ®Google Scholar
• Eichenauer DA, Aleman BMP, André M, et al. Hodgkin lymphoma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2018;29(Suppl. 4):iv19–iv29.
   PubMed Web of Science ®Google Scholar
• Opie J. Haematological complications of HIV infection. S Afr Med J. 2012;102(6):465–468.
   PubMed Web of Science ®Google Scholar
• Van den Berg K, Murphy EL, Pretorius L, et al. The impact of HIV-associated anaemia on the incidence of red blood cell transfusion: implications for blood services in HIV-endemic countries. Transfus Apher Sci. 2014;51(3):10–18.
   PubMed Web of Science ®Google Scholar
• Skoetz N, Will A, Monsef I, et al. Comparison of first-line chemotherapy including escalated BEACOPP versus chemotherapy including ABVD for people with early unfavourable or advanced stage Hodgkin lymphoma. Cochrane Database Syst Rev. 2017;5(5):CD007941.
   PubMedGoogle Scholar
• Kelly KM, Sposto R, Hutchinson R, et al. BEACOPP chemotherapy is a highly effective regimen in children and adolescents with high-risk Hodgkin lymphoma: a report from the Children’s Oncology Group. Blood. 2011;117(9):2596–2603.
   PubMed Web of Science ®Google Scholar
• Howell SJ, Grey M, Chang J, et al. The value of bone marrow examination in the staging of Hodgkin’s lymphoma: a review of 955 cases seen in a regional cancer centre. Br J Haematol. 2002;119(2):408–411.
   PubMed Web of Science ®Google Scholar
• Vassilakopoulos TP, Angelopoulou MK, Constantinou N, et al. Development and validation of a clinical prediction rule for bone marrow involvement in patients with Hodgkin lymphoma. Blood. 2005;105(5):1875–1880.
   PubMed Web of Science ®Google Scholar
• Swart L, Novitzky N, Mohamed Z, et al. Hodgkin lymphoma at Groote Schuur Hospital, South Africa: the effect of HIV and bone marrow infiltration. Ann Hematol. 2019;98(2):381–389.
   PubMed Web of Science ®Google Scholar
• Mangla A, Mushtaq MU, Kumar R, et al. Prognostic significance of bone marrow involvement in Hodgkin lymphoma. Blood. 2016;128(22):5370–5370.
   Google Scholar
• Moccia AA, Donaldson J, Chhanabhai M, et al. International Prognostic Score in advanced-stage Hodgkin’s lymphoma: altered utility in the modern era. J Clin Oncol. 2012;30(27):3383–3388.
   PubMed Web of Science ®Google Scholar